Shares of biotech Juno, already up 50% on deal hopes, skyrocket on actual Celgene $9 billion offer

Jan 22, 2018 | Media Highlights | 0 comments

featured on cnbc
You May Also Like

0 Comments

Submit a Comment

Get In Touch